LUTETIUM (177lu) CHLORIDE (Australian Nuclear Science and Technology Organisation)
Product name
LUTETIUM (177lu) CHLORIDE
Date registered
Evaluation commenced
Decision date
Approval time
189 (255 working days)
Active ingredients
lutetium (177lu) chloride
Registration type
NCE/NBE
Indication
LUTETIUM (177lu) CHLORIDE (radiochemical solution for injection) is a radiopharmaceutical precursor, and it is not intended for direct use in patients. For the treatment of non resectable or metastatic neuroendocrine tumours (NETS) expressing somatostatin subtype 2 receptors when coupled with a suitable carrier molecule.
Registration process
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.